cromakalim has been researched along with 6-cyano-7-nitroquinoxaline-2,3-dione in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biggs, CS; Fowler, LJ; Maione, S; Rossi, F; Whitton, PS | 1 |
1 other study(ies) available for cromakalim and 6-cyano-7-nitroquinoxaline-2,3-dione
| Article | Year |
|---|---|
AMPA receptors modulate extracellular 5-hydroxytryptamine concentration and metabolism in rat striatum in vivo.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Antihypertensive Agents; Benzopyrans; Corpus Striatum; Cromakalim; Diazoxide; Excitatory Amino Acid Antagonists; Hydroxyindoleacetic Acid; Male; Pyrroles; Rats; Rats, Wistar; Receptors, AMPA; Serotonin; Vasodilator Agents | 1997 |